Table 5.
Characteristics of long-term survivors (≥ 24 months)
| Age (years),a gender, ASA | Jaundicea | Procedure | pTNM R status | Perineural invasion | Vascular invasion | Liver invasion | CBD invasion | Follow-up (months) | Status |
|---|---|---|---|---|---|---|---|---|---|
| 65, M, 2 | Yes | PD |
T3N0M0 R0 |
No | No | Yes | No | 24 | Deceased, recurrence |
| 63, M, 2 | Yes | RH |
T2N0M0 R1 |
Yes | Yes | No | No | 24 | Alive, with recurrence |
| 67, F, 2 | No | RH |
T4N1M0 R0 |
Yes | No | No | No | 27 | Deceased, recurrence |
| 79, F, 2 | No | PD |
T2N2M0 R1 |
No | Yes | No | No | 29 | Deceased, recurrence |
| 63, M, 3 | Yes | PD |
T4N1M0 R1 |
Yes | No | No | No | 39 | Deceased, recurrence |
| 46, M, 2 | Yes | RH + PD |
T3N1M0 R0 |
Yes | Yes | Yes | Yes | 49 | Deceased, recurrence |
| 69, F, 2 | Yes | RH + PD |
T4N2M1 R1 |
Yes | No | No | No | 71 | Deceased, recurrence |
| 65, M, 3 | No | RH |
T3N0M0 R0 |
Yes | No | No | Yes | 86 | Alive, no recurrence |
| 53, F, 1 | No | RH |
T2N2M0 R0 |
No | No | No | No | 91 | Alive, no recurrence |
| 68, F, 2 | No | PD |
T3N0M0 R0 |
No | No | No | No | 119 | Alive, no recurrence |
ASA American Society of Anesthesiologists, pTNM pathologic tumor-node metastasis, CBD common bile duct, M male, PD pancreatoduodenectomy, RH right hemihepatectomy, F female
aAt presentation